Avaxzipen LIMITED
Doing business as Enesi Pharma
- UEI
- KLMEDM8J3UK3
- CAGE
- U1HD7
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- avaxmed.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Enesi evaluation of novel solid dose vaccines for use in a future pandemic influenza | Office of the Assistant Secretary for Preparedness and Response | $688,863 |
Quick answers
What is Avaxzipen LIMITED's UEI?
Avaxzipen LIMITED's Unique Entity ID (UEI) in SAM.gov is KLMEDM8J3UK3.
What is Avaxzipen LIMITED's CAGE code?
Avaxzipen LIMITED's CAGE code is U1HD7.
What is Avaxzipen LIMITED's primary NAICS code?
Avaxzipen LIMITED's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Is Avaxzipen LIMITED registered in SAM.gov?
Avaxzipen LIMITED's SAM.gov registration expired on January 2, 2026.
What is Avaxzipen LIMITED's most recent federal award?
Avaxzipen LIMITED's most recent federal contract award is Enesi evaluation of novel solid dose vaccines for use in a future pandemic influenza (75A50119C00032), from Office of the Assistant Secretary for Preparedness and Response, on April 2, 2019.
On GovTribe
See Avaxzipen LIMITED's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors